Literature DB >> 12424719

Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates.

Cynthia L Cotton1, Sanjay Gandhi, Paul T Vaitkus, Malek G Massad, Enrico Benedetti, Robert G Mrtek, Thelma E Wiley.   

Abstract

Portopulmonary hypertension (PPHTN) is a recognized complication of end-stage liver disease that adversely affects the outcome of orthotopic liver transplantation (OLT). There are limited data on the role of Doppler echocardiography in assessing pulmonary artery systolic pressure (PASP) in this population. The purpose of our study was to examine the accuracy of Doppler echocardiography in evaluating pulmonary artery pressures in liver transplant candidates. Clinical and demographic data were gathered retrospectively for 78 liver transplant candidates (48 men and 30 women, mean age 51 +/- 9.6 yr) who had PASP determined both by right heart catheterization (RHC) and echocardiography. Paired sample t-test was used to compare mean PASP by echocardiography and RHC. Correlation of PASP between echocardiography and RHC was determined using Pearson's linear correlation. Positive and negative predictive values for echocardiography for PASP > 50 mmHg are reported as compared with RHC. The mean PASP by echocardiography (43.2 +/- 12.3 mm Hg) was significantly higher than mean PASP by RHC (33.7 +/- 15.5 mm Hg; P <.001). Regarding PASP, there was a significant but weak correlation between echocardiography and RHC (r = 0.46, P =.01). The positive and negative predictive values of echocardiography for identifying clinically significant pulmonary hypertension (PASP > 50 mm Hg) were 37.5% and 91.9%, respectively. Echocardiography is a useful tool in estimating PASP in liver transplant candidates. Patients with apparently elevated PASP by echocardiography should undergo invasive assessment by RHC before being excluded from liver transplant.

Entities:  

Mesh:

Year:  2002        PMID: 12424719     DOI: 10.1053/jlts.2002.35554

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  14 in total

1.  Portopulmonary hypertension: challenges in diagnosis and management.

Authors:  Patrick J Troy; Aaron B Waxman
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

2.  Portopulmonary hypertension in pediatric patients.

Authors:  Adria A Condino; D Dunbar Ivy; Judith A O'Connor; Michael R Narkewicz; Sarah Mengshol; John R Whitworth; Lori Claussen; Aimee Doran; Ronald J Sokol
Journal:  J Pediatr       Date:  2005-07       Impact factor: 4.406

3.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

Review 4.  Ultrasonography in the diagnosis of complications in patients with portal hypertension.

Authors:  Hisashi Hidaka; Haruki Uojima
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.878

Review 5.  Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.

Authors:  Yasushi Tsujimoto; Junji Kumasawa; Sayaka Shimizu; Yoshio Nakano; Yuki Kataoka; Hiraku Tsujimoto; Michihiko Kono; Shinji Okabayashi; Haruki Imura; Takahiro Mizuta
Journal:  Cochrane Database Syst Rev       Date:  2022-05-09

6.  The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension.

Authors:  Yuksel Dogan; Aliye Soylu; Ozgur Kilickesmez; Tuna Demirtas; Kadriye Orta Kilickesmez; Sebahat Nacar Dogan; Gulay Eren; Isa Sevindir; Nurgul Yasar; Sule Poturoglu; Kenan Sonmez
Journal:  Cardiovasc Ultrasound       Date:  2010-07-21       Impact factor: 2.062

7.  Pulmonary vascular complications in asymptomatic children with portal hypertension.

Authors:  John R Whitworth; D Dunbar Ivy; Jane Gralla; Michael R Narkewicz; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-11       Impact factor: 2.839

8.  Management of cardiopulmonary complications of cirrhosis.

Authors:  Prabha Sawant; C Vashishtha; M Nasa
Journal:  Int J Hepatol       Date:  2011-07-19

9.  Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors.

Authors:  Hui-Song Chen; Su-Rong Xing; Wei-Guo Xu; Fan Yang; Xiao-Long Qi; LE-Min Wang; Chang-Qing Yang
Journal:  Exp Ther Med       Date:  2013-01-22       Impact factor: 2.447

10.  Hepatopulmonary syndrome and portopulmonary hypertension.

Authors:  Adrian Hendrickse; Fareed Azam; M Susan Mandell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.